×

Premium Content - Please Submit to Continue:

First Name
Last Name
Company
Thank you!
Error - something went wrong!
   

Reducing the Burden of Data Collection in Oncology Trials

February 23, 2017 Jackie Brusch

Understanding patient reported outcomes (PROs) in oncology clinical trials enables researchers to develop more effective treatments for patients battling this illness. But if it isn't easy for patients to report their health data, they won't - so it must be accessible for them.

Electronic Clinical Outcome Assessment (eCOA) solutions allow seriously ill cancer patients to participate in clinical trials by offering them the ability to submit their data remotely, from the comfort of home, or at the hospital while receiving care. Patient-friendly features reduce burden, increase engagement and compliance, and ensure ALCOA principles are met for accurate, timely data capture.

Download the whitepaper to learn more about how eCOA is changing the way cancer patients contribute to finding a cure. 

Previous
Making the Switch: Improving Study Outcomes with eCOA Technology in Vaccine Clinical Trials
Making the Switch: Improving Study Outcomes with eCOA Technology in Vaccine Clinical Trials

Many people are not getting the vaccinations they need to avoid death and disease. Electronic Clinical Outc...

Next
Understanding the EMA Oncology PRO Guideline Appendix – We Can Help!
Understanding the EMA Oncology PRO Guideline Appendix – We Can Help!